BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 3, 2011
View Archived Issues
Novartis reflects on accomplishments of second quarter 2011
Read More
Byetta is safe and effective in Prader-Willi syndrome
Read More
Pfizer presents new MABA as clinical candidate for COPD
Read More
Diagnostic ability of PET tracer flutemetamol investigated in AD, MCI and NPH
Read More
Sanofi discloses novel protein kinase inhibitors
Read More
Takeda presents new histamine H3 receptor antagonists
Read More
Novel agents for protozoal infections claimed by Actelion
Read More
Piramal Life Sciences claims new diacylglycerol O-acyltransferase inhibitors
Read More
Katholieke Universiteit Leuven prepares novel antibacterials
Read More
Trial measures lorcaserin exposure in human cerebrospinal fluid
Read More
Femta Pharmaceuticals files IND with FDA for FM-101
Read More
Cardium Therapeutics provides update on plan to acquire Transdel
Read More
Noninvasive diabetes screening test obtains CE mark
Read More
Critical Outcome Technologies begins synthesis of AML drug candidates
Read More
FDA accepts NDA filing for Levadex
Read More
Genzyme seeks approval for mipomersen in Europe
Read More
Protalix replies to FDA complete response letter for taliglucerase alfa
Read More
AAV-mediated gene editing using ZFN technology shows promise to treat hemophilia in vivo
Read More
Alnylam completes phase I ALN-VSP trial
Read More
OncoTherapy Science's anticancer vaccine OTS-102 obtains generic name
Read More
Amarin completes remaining studies of AMR-101 required for NDA
Read More
Bionomics provides update on clinical trials of anticancer candidate BNC-105
Read More
Encouraging interim results emerge from phase III study of Paclical
Read More
EMA provides scientific advice regarding phase III trial of CPP-1X in FAP
Read More
European Commission expands RoActemra label
Read More